secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001005286-25-000138
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud

Lifecore Biomedical stockholders elect nine directors and ratify KPMG at 2025 annual meeting
--------------------------------------------------------------------------------

- Katrina L. Houde, Humberto C. Antunes, Paul H. Johnson, Paul Josephs, Matthew E. Korenberg, Nelson Obus, Joshua E. Schechter elected by common and Series A holders.
- Series A preferred stockholders elected Jason Aryeh and Christopher S. Kiper as directors with 38,776 votes for each.
- Ratification of KPMG LLP as independent auditor for fiscal 2025 received 35,663,643 votes for, 15,326 against.
- Non-binding advisory vote on named executive officer compensation approved with 24,642,130 votes for, 238,354 against.
- A total of 37,436,784 common shares and 46,593 Series A preferred shares were outstanding on the record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528625000138/0001005286-25-000138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528625000138/lfcr-20251029.htm
  HTML page:      https://secwatch.observer/filing/0001005286-25-000138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer